{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:16:27Z","timestamp":1793121387261,"version":"4.5.0"},"reference-count":240,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.preteyeres.2020.100901","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T07:40:48Z","timestamp":1599205248000},"page":"100901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"special_numbering":"C","title":["Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma"],"prefix":"10.1016","volume":"82","author":[{"given":"Uday B.","family":"Kompella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel R.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhoosudan A.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2020.100901_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nano. Res. Lett."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib2","first-page":"S3","article-title":"Evolving guidelines for intravitreous injections","volume":"24","author":"Aiello","year":"2004","journal-title":"Retina-the Journal of Retinal and Vitreous Diseases"},{"issue":"7","key":"10.1016\/j.preteyeres.2020.100901_bib3","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1172\/JCI91948","article-title":"Targeting neuronal gap junctions in mouse retina offers neuroprotection in glaucoma","volume":"127","author":"Akopian","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.preteyeres.2020.100901_bib4","series-title":"U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension","author":"Allergan","year":"2019"},{"key":"10.1016\/j.preteyeres.2020.100901_bib5","series-title":"Allergan Receives FDA Approval for DURYSTA (Bimatoprost Implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to Lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Patients","author":"Allergan","year":"2020"},{"key":"10.1016\/j.preteyeres.2020.100901_bib6","author":"Allergan"},{"key":"10.1016\/j.preteyeres.2020.100901_bib7","series-title":"Prescribing Information","author":"Allergan","year":"2020"},{"key":"10.1016\/j.preteyeres.2020.100901_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-vision-102016-061422","article-title":"Neuroprotection in glaucoma: animal models and clinical trials","volume":"3 3","author":"Almasieh","year":"2017","journal-title":"Annual Review of Vision Science"},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00137696-200604030-00002","article-title":"Contact lenses for drug delivery","volume":"4","author":"Alvarez-Lorenzo","year":"2006","journal-title":"Am. J. Drug Deliv."},{"issue":"12","key":"10.1016\/j.preteyeres.2020.100901_bib10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","article-title":"Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration","volume":"57","author":"Amrite","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1167\/iovs.05-0531","article-title":"Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2,VEGF, and vascular leakage","volume":"47","author":"Amrite","year":"2006","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-4835(91)90125-X","article-title":"The loss OF fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous BY the anterior and retinal pathways","volume":"52","author":"Araie","year":"1991","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2020.100901_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2019.01.012","article-title":"Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma","volume":"297","author":"Arranz-Romera","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2020.100901_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/IAE.0000000000000399","article-title":"Intravitreal injection technique and monitoring: updated guidelines of an expert panel","volume":"34","author":"Avery","year":"2014","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib15","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1023\/B:PHAM.0000045231.51924.e8","article-title":"Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration","volume":"21","author":"Ayalasomayajula","year":"2004","journal-title":"Pharmaceut. Res."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.exer.2010.08.009","article-title":"Neuroprotection in glaucoma - is there a future role?","volume":"91","author":"Baltmr","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/bjophthalmol-2016-308710","article-title":"Twenty-four hour intraocular pressure monitoring with the SENSIMED Triggerfish contact lens: effect of body posture during sleep","volume":"101","author":"Beltran-Agullo","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2020.100901_bib18","author":"Boyd"},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.ophtha.2016.04.026","article-title":"Six-month intraocular pressure reduction with a topical bimatoprost ocular insert results of a phase II randomized controlled study","volume":"123","author":"Brandt","year":"2016","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib20","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.ophtha.2017.04.022","article-title":"Long-term safety and efficacy of a sustained-release bimatoprost ocular ring","volume":"124","author":"Brandt","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-1978-24702","article-title":"Cascade-chain-like and nonskid-chain-like syntheses of molecular cavity topologies","author":"Buhleier","year":"1978","journal-title":"Synthesis (Stuttgart)"},{"key":"10.1016\/j.preteyeres.2020.100901_bib22","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0039-6257(96)82027-3","article-title":"Preclinical evaluation of brimonidine","volume":"41","author":"Burke","year":"1996","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.preteyeres.2020.100901_bib23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.preteyeres.2012.07.001","article-title":"Critical pathogenic events underlying progression of neurodegeneration in glaucoma","volume":"31","author":"Calkins","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archophthalmol.2010.19","article-title":"Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis","volume":"128","author":"Campbell","year":"2010","journal-title":"Arch. Ophthalmol."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bjo.2006.110155","article-title":"Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract","volume":"91","author":"Cantor","year":"2007","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.preteyeres.2020.100901_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/IJG.0b013e318162257f","article-title":"Absorption of brimonidine 0.1% and 0.15% ophthalmic solutions in the aqueous humor of cataract patients","volume":"17","author":"Cantor","year":"2008","journal-title":"J. Glaucoma"},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib27","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00417-014-2866-1","article-title":"Quantifying silicone oil emulsification in patients: are we only seeing the tip of the iceberg?","volume":"253","author":"Chan","year":"2015","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2011.06.023","article-title":"Retinal ganglion cells survival in a glaucoma model by GDNF\/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure","volume":"156","author":"Checa-Casalengua","year":"2011","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.medengphy.2014.06.005","article-title":"Soft wearable contact lens sensor for continuous intraocular pressure monitoring","volume":"36","author":"Chen","year":"2014","journal-title":"Med. Eng. Phys."},{"key":"10.1016\/j.preteyeres.2020.100901_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biomaterials.2016.09.028","article-title":"An immobilized liquid interface prevents device associated bacterial infection in vivo","volume":"113","author":"Chen","year":"2017","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib31","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1021\/nn5029955","article-title":"Acceleration of tissue plasminogen activator-mediated thrombolysis by magnetically powered nanomotors","volume":"8","author":"Cheng","year":"2014","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2018.09.041","article-title":"Effect of ciliary neurotrophic factor on retinal neurodegeneration in patients with macular telangiectasia type 2 A randomized clinical trial","volume":"126","author":"Chew","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2020.100901_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2016.02.041","article-title":"Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma","volume":"228","author":"Chiang","year":"2016","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.preteyeres.2020.100901_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ma11071125","article-title":"Therapeutic contact lenses with polymeric vehicles for ocular drug delivery: a review","volume":"11","author":"Choi","year":"2018","journal-title":"Materials"},{"issue":"7","key":"10.1016\/j.preteyeres.2020.100901_bib35","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1167\/iovs.08-2826","article-title":"A drug-eluting contact lens","volume":"50","author":"Ciolino","year":"2009","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biomaterials.2013.09.032","article-title":"In vivo performance of a drug-eluting contact lens to treat glaucoma for a month","volume":"35","author":"Ciolino","year":"2014","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib37","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.ophtha.2016.06.038","article-title":"Latanoprost-eluting contact lenses in glaucomatous monkeys","volume":"123","author":"Ciolino","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.preteyeres.2020.100901_bib38","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.nano.2012.03.009","article-title":"Surface modification of PAMAM dendrimer improves its biocompatibility","volume":"8","author":"Ciolkowski","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1109\/TBME.1967.4502474","article-title":"Miniature passive pressure transensor for implanting in the eye","volume":"14","author":"Collins","year":"1967","journal-title":"IEEE Transactions on Biomedical Engineering BME-"},{"issue":"14","key":"10.1016\/j.preteyeres.2020.100901_bib40","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/ie000596z","article-title":"Dispersive mixing in the posterior tear film under a soft contact lens","volume":"40","author":"Creech","year":"2001","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.preteyeres.2020.100901_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","article-title":"Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases","volume":"43","author":"Cuenca","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib42","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/jps.20871","article-title":"Antibacterial activity of contact lenses bearing surface-immobilized layers of intact Liposomes loaded with Levofloxacin","volume":"96","author":"Danion","year":"2007","journal-title":"J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jbm.a.31147","article-title":"Fabrication and characterization of contact lenses bearing surface-immobilized layers of intact liposomes","volume":"82A","author":"Danion","year":"2007","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.preteyeres.2020.100901_bib44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41467-017-00309-w","article-title":"Micromotor-enabled active drug delivery for in vivo treatment of stomach infection","volume":"8","author":"De Avila","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2020.100901_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40123-019-0161-2","article-title":"Miniaturization in glaucoma monitoring and treatment: a review of new Technologies that require a minimal surgical approach","volume":"8","author":"Dick","year":"2019","journal-title":"Ophthalmology and Therapy"},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib47","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s13346-018-0541-5","article-title":"Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation","volume":"8","author":"Dixon","year":"2018","journal-title":"Drug Delivery and Translational Research"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib49","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1167\/iovs.08-2078","article-title":"Alpha 2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity","volume":"49","author":"Dong","year":"2008","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib50","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1167\/iovs.11-7955","article-title":"24-Hour IOP telemetry in the nonhuman primate: implant system performance and initial characterization of IOP at multiple timescales","volume":"52","author":"Downs","year":"2011","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00003226-200304000-00004","article-title":"Diurnal variation of corneal sensitivity and thickness","volume":"22","author":"Du Toit","year":"2003","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40262-014-0183-9","article-title":"Optimal sampling scheme for estimation of intraocular pressure diurnal curves in glaucoma trials","volume":"54","author":"Durairaj","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.preteyeres.2020.100901_bib53","series-title":"Pharmacologic Therapy of Ocular Disease","first-page":"31","article-title":"Ocular pharmacokinetics","author":"Durairaj","year":"2017"},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib54","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1167\/iovs.09-3565","article-title":"Influence of dosage form on the intravitreal pharmacokinetics of diclofenac","volume":"50","author":"Durairaj","year":"2009","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib55","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s11095-008-9728-7","article-title":"Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR)","volume":"26","author":"Durairaj","year":"2009","journal-title":"Pharmaceut. Res."},{"issue":"11","key":"10.1016\/j.preteyeres.2020.100901_bib56","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1167\/iovs.10-5392","article-title":"Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications","volume":"51","author":"Edelhauser","year":"2010","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcyt.2014.12.005","article-title":"Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model","volume":"17","author":"Emre","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.preteyeres.2020.100901_bib243","unstructured":"Envisia (Press Release 2017) Envisia Therapeutics Press Releases; Interim ENV515 (Travoprost XR) Phase 2 Data Demonstrating 11-month Duration-of-Action After a Single Dose in Patients With Glaucoma.) PR Newswire, available at: https:\/\/www.prnewswire.com\/news-releases\/envWoSa-therapeutics-releases-interim-env515-travoprost-xr-phase-2-data-demonstrating-11-month-duration-of-action-after-a-single-dose-in-patients-with-glaucoma-300401812.html."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib58","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/ceo.12026","article-title":"Intravitreal injections: a review of the evidence for best practice","volume":"41","author":"Fagan","year":"2013","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ijpharm.2018.07.012","article-title":"Treatment merits of Latanoprost\/Thymoquinone - encapsulated liposome for glaucomatus rabbits","volume":"548","author":"Fahmy","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/jop.2009.0098","article-title":"Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN (R) or TRAVATAN (R)","volume":"26","author":"Faulkner","year":"2010","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.preteyeres.2020.100901_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09379-8","article-title":"Long term glaucoma drug delivery using a topically retained gel\/microsphere eye drop","volume":"7","author":"Fedorchak","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5090079","article-title":"Adherence to glaucoma medications over 12 Months in two US community pharmacy chains","volume":"5","author":"Feehan","year":"2016","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajo.2014.03.015","article-title":"Effect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma","volume":"158","author":"Feke","year":"2014","journal-title":"Am. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib64","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ophtha.2005.02.030","article-title":"Glaucoma management among individuals enrolled in a single comprehensive insurance plan","volume":"112","author":"Friedman","year":"2005","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib65","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1021\/acs.molpharmaceut.6b00343","article-title":"Subconjunctival delivery of dorzolamide-loaded poly(ether-anhydride) microparticles produces sustained lowering of intraocular pressure in rabbits","volume":"13","author":"Fu","year":"2016","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.preteyeres.2020.100901_bib66","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archopht.120.6.797","article-title":"Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells","volume":"120","author":"Gao","year":"2002","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1021\/nn507097k","article-title":"Artificial micromotors in the mouse's stomach: a step toward in vivo use of synthetic motors","volume":"9","author":"Gao","year":"2015","journal-title":"ACS Nano"},{"issue":"9975","key":"10.1016\/j.preteyeres.2020.100901_bib68","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.preteyeres.2020.100901_bib69","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/nl900186w","article-title":"Controlled propulsion of artificial magnetic nanostructured propellers","volume":"9","author":"Ghosh","year":"2009","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1021\/mp049886u","article-title":"Biological evaluation of polyester dendrimer: poly(ethylene oxide) \"Bow-Tie\" hybrids with tunable molecular weight and architecture","volume":"2","author":"Gillies","year":"2005","journal-title":"Mol. Pharm."},{"issue":"14","key":"10.1016\/j.preteyeres.2020.100901_bib71","first-page":"5095","article-title":"A phase 2 study evaluating safety and efficacy of the latanoprost punctal plug delivery system (L-PPDS) in subjects with ocular hypertension (OH) or open-angle glaucoma (OAG)","volume":"53","author":"Goldberg","year":"2012","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.preteyeres.2020.100901_bib72","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1167\/iovs.03-0959","article-title":"Ophthalmic drug delivery through contact lenses","volume":"45","author":"Gulsen","year":"2004","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"1\u20132","key":"10.1016\/j.preteyeres.2020.100901_bib73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2004.11.033","article-title":"Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle","volume":"292","author":"Gulsen","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.preteyeres.2020.100901_bib74","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/02713680500346633","article-title":"Dispersion of DMPC liposomes in contact lenses for ophthalmic drug delivery","volume":"30","author":"Gulsen","year":"2005","journal-title":"Curr. Eye Res."},{"issue":"1\u20132","key":"10.1016\/j.preteyeres.2020.100901_bib75","first-page":"185","article-title":"Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells","volume":"393","author":"Gupta","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10544-011-9598-3","article-title":"Polymer-based miniature flexible capacitive pressure sensor for intraocular pressure (IOP) monitoring inside a mouse eye","volume":"14","author":"Ha","year":"2012","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.preteyeres.2020.100901_bib77","author":"Haddrill"},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib78","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1167\/iovs.03-0566","article-title":"Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: functional measures","volume":"45","author":"Hare","year":"2004","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"1\u20132","key":"10.1016\/j.preteyeres.2020.100901_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/jop.2017.0121","article-title":"Intravitreal, subretinal, and suprachoroidal injections: evolution of microneedles for drug delivery","volume":"35","author":"Hartman","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib80","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/00006324-199910000-00023","article-title":"Re-evaluation of the oxygen diffusion model for predicting minimum contact lens Dk\/t values needed to avoid corneal anoxia","volume":"76","author":"Harvitt","year":"1999","journal-title":"Optom. Vis. Sci."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib81","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1116\/1.2764082","article-title":"Glancing angle deposition: fabrication, properties, and applications of micro- and nanostructured thin films","volume":"25","author":"Hawkeye","year":"2007","journal-title":"J. Vac. Sci. Technol."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib82","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s002280050635","article-title":"Improved penetration of aminoglycosides and fluoroquinolones into the aqueous humour of patients by means of Acuvue contact lenses","volume":"55","author":"Hehl","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib83","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression - results from the early manifest glaucoma trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch. Ophthalmol."},{"issue":"6","key":"10.1016\/j.preteyeres.2020.100901_bib84","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ajo.2011.05.015","article-title":"A video study of drop instillation in both glaucoma and retina patients with visual impairment","volume":"152","author":"Hennessy","year":"2011","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib85","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.exer.2008.02.008","article-title":"Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments","volume":"86","author":"Hernandez","year":"2008","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib86","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(02)00213-4","article-title":"Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid","volume":"83","author":"Hiratani","year":"2002","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.preteyeres.2020.100901_bib87","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biomaterials.2004.04.030","article-title":"Ocular release of timolol from molecularly imprinted soft contact lenses","volume":"26","author":"Hiratani","year":"2005","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib88","first-page":"1161","article-title":"Critical oxygen levels to avoid corneal edema for daily and extended wear contact-lenses","volume":"25","author":"Holden","year":"1984","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib89","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nano.2011.08.018","article-title":"Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs","volume":"8","author":"Holden","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"12","key":"10.1016\/j.preteyeres.2020.100901_bib90","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1517\/14656566.2014.936850","article-title":"Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice","volume":"15","author":"Hollo","year":"2014","journal-title":"Expet Opin. Pharmacother."},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib91","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s12325-014-0151-7","article-title":"Fixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products","volume":"31","author":"Hollo","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.preteyeres.2020.100901_bib92","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejpb.2015.06.001","article-title":"Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy","volume":"94","author":"Hsu","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib93","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1111\/aos.12241","article-title":"Effect of overnight wear of the Triggerfish((R)) sensor on corneal thickness measured by Visante((R)) anterior segment optical coherence tomography","volume":"92","author":"Hubanova","year":"2014","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib94","first-page":"167","article-title":"Experimental model of intravitreal injection techniques","volume":"30","author":"Hubschman","year":"2010","journal-title":"Retina-the Journal of Retinal and Vitreous Diseases"},{"issue":"12","key":"10.1016\/j.preteyeres.2020.100901_bib95","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jamaophthalmol.2014.3333","article-title":"Persistence of topical glaucoma medication A nationwide population-based cohort study in taiwan","volume":"132","author":"Hwang","year":"2014","journal-title":"Jama Ophthalmology"},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib96","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/biom9080330","article-title":"Cytotoxicity of dendrimers","volume":"9","author":"Janaszewska","year":"2019","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib97","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.4.4.371","article-title":"Novel approaches to retinal drug delivery","volume":"4","author":"Janoria","year":"2007","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.preteyeres.2020.100901_bib98","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9312340","article-title":"Comprehensive review of the literature on existing punctal plugs for the management of dry eye disease","author":"Jehangir","year":"2016","journal-title":"J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib99","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1023\/A:1026166729873","article-title":"Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity","volume":"20","author":"Jevprasesphant","year":"2003","journal-title":"Pharmaceut. Res."},{"issue":"1\u20132","key":"10.1016\/j.preteyeres.2020.100901_bib100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0378-5173(02)00623-3","article-title":"The influence of surface modification on the cytotoxicity of PAMAM dendrimers","volume":"252","author":"Jevprasesphant","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2020.100901_bib101","article-title":"What to know about punctal plugs for dry eye","author":"Johnson","year":"2018","journal-title":"Medical News Today"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib102","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1167\/iovs.09-4509","article-title":"Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma","volume":"51","author":"Johnson","year":"2010","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib103","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.biomaterials.2008.10.032","article-title":"Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs","volume":"30","author":"Kapoor","year":"2009","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.ICL.0000061756.66151.1C","article-title":"Ciprofloxacin interaction with silicon-based and conventional hydrogel contact lenses","volume":"29","author":"Karlgard","year":"2003","journal-title":"Eye Contact Lens"},{"issue":"1\u20132","key":"10.1016\/j.preteyeres.2020.100901_bib105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00124-8","article-title":"In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials","volume":"257","author":"Karlgard","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib106","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/S0161-6420(01)00793-X","article-title":"Intracameral anesthesia - a report by the American academy of ophthalmology","volume":"108","author":"Karp","year":"2001","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib107","doi-asserted-by":"crossref","first-page":"693","DOI":"10.22270\/jddt.v9i4.3207","article-title":"Ocular inserts - a novel approach in ocular drug delivery","volume":"9","author":"Khan","year":"2019","journal-title":"J. Drug Deliv. Therapeut."},{"key":"10.1016\/j.preteyeres.2020.100901_bib108","first-page":"1","article-title":"Neuroprotection in glaucoma: towards clinical trials and precision medicine","author":"Khatib","year":"2019","journal-title":"Curr. Eye Res."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib109","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/02713683.2019.1663385","article-title":"Neuroprotection in glaucoma: towards clinical trials and precision medicine","volume":"45","author":"Khatib","year":"2020","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IIO.0000000000000062","article-title":"Intravitreal injections and endophthalmitis","volume":"55","author":"Kim","year":"2015","journal-title":"Int. Ophthalmol. Clin."},{"issue":"14","key":"10.1016\/j.preteyeres.2020.100901_bib111","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.biomaterials.2008.01.030","article-title":"Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses","volume":"29","author":"Kim","year":"2008","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib112","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11095-007-9408-z","article-title":"Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging","volume":"25","author":"Kim","year":"2008","journal-title":"Pharmaceut. Res."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib113","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1021\/nn5002968","article-title":"Diamond nanogel-embedded contact lenses mediate lysozyme-dependent therapeutic release","volume":"8","author":"Kim","year":"2014","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.preteyeres.2020.100901_bib114","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.1167\/iovs.14-14651","article-title":"Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles","volume":"55","author":"Kim","year":"2014","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/ICB.0000000000000327","article-title":"Epiretinal membrane formation after intravitreal autologous stem cell implantation in A retinitis pigmentosa patient","volume":"11","author":"Kim","year":"2017","journal-title":"Retin. Cases Brief Rep.: Summer"},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib116","doi-asserted-by":"crossref","first-page":"199","DOI":"10.18388\/abp.2001_5127","article-title":"Dendrimers: properties and applications","volume":"48","author":"Klajnert","year":"2001","journal-title":"Acta Biochim. Pol."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib117","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1167\/iovs.02-0791","article-title":"Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression","volume":"44","author":"Kompella","year":"2003","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2020.100901_bib118","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4155\/tde.10.40","article-title":"Recent advances in ophthalmic drug delivery","volume":"1","author":"Kompella","year":"2010","journal-title":"Ther. Deliv."},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib119","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.eye.6701345","article-title":"Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma","volume":"18","author":"Konstas","year":"2004","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib120","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1167\/iovs.14-14925","article-title":"Implantation of a novel telemetric intraocular pressure sensor in patients with glaucoma (ARGOS study): 1-year results","volume":"56","author":"Koutsonas","year":"2015","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.preteyeres.2020.100901_bib121","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the low-pressure glaucoma treatment study (vol 151, pg 671, 2011)","volume":"151","author":"Krupin","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2020.100901_bib122","series-title":"Nanostructures for Drug Delivery","article-title":"Therapeutic nanomaterials: from a drug delivery perspective","author":"Kumar","year":"2017"},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib123","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.4.1.1","article-title":"Nanosponge-mediated drug delivery lowers intraocular pressure","volume":"4","author":"Lambert","year":"2015","journal-title":"Translational Vision Science & Technology"},{"issue":"17","key":"10.1016\/j.preteyeres.2020.100901_bib124","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199804233381702","article-title":"Topical treatment with nerve growth factor for corneal neurotrophic ulcers","volume":"338","author":"Lambiase","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib125","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2435-0","article-title":"Extended pharmacokinetic model of the rabbit eye for intravitreal and intracameral injections of macromolecules: quantitative analysis of anterior and posterior elimination pathways","volume":"35","author":"Lamminsalo","year":"2018","journal-title":"Pharmaceut. Res."},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib126","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/acsbiomaterials.7b00319","article-title":"Fast dissolving dendrimer nanofiber mats as alternative to eye drops for more efficient antiglaucoma drug delivery","volume":"3","author":"Lancina","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207190","article-title":"Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma","volume":"14","author":"Lauzi","year":"2019","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib128","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/jop.2016.0042","article-title":"Sustained delivery of timolol maleate for over 90 Days by subconjunctival injection","volume":"32","author":"Lavik","year":"2016","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems - recent advances","volume":"17","author":"Le Bourlais","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib240","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/jop.2018.0095","article-title":"Dose-response of intracameral bimatoprost sustained-release implant and topical bimatoprost in lowering intraocular pressure","volume":"35","author":"Lee","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/108076804772745464","article-title":"Drug delivery to the posterior segment of the eye III: the effect of parallel elimination pathway on the vitreous drug level after subconjunctival injection","volume":"20","author":"Lee","year":"2004","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib131","first-page":"975","article-title":"Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells","volume":"42","author":"Levkovitch-Verbin","year":"2001","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2020.100901_bib132","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2016.11.020","article-title":"Bimatoprost sustained-release implants for glaucoma therapy: 6-month results from a phase I\/II clinical trial","volume":"175","author":"Lewis","year":"2017","journal-title":"Am. J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib133","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ie0507934","article-title":"Modeling ophthalmic drug delivery by soaked contact lenses","volume":"45","author":"Li","year":"2006","journal-title":"Ind. Eng. Chem. Res."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib134","doi-asserted-by":"crossref","DOI":"10.1126\/scirobotics.aam6431","article-title":"Micro\/nanorobots for biomedicine: delivery, surgery, sensing, and detoxification","volume":"2","author":"Li","year":"2017","journal-title":"Science Robotics"},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bjo.86.3.355","article-title":"Microbial keratitis associated with extended wear of silicone hydrogel contact lenses","volume":"86","author":"Lim","year":"2002","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib136","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1167\/iovs.02-0666","article-title":"Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes","volume":"44","author":"Liu","year":"2003","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib137","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archopht.1975.01010020571003","article-title":"Pilocarpine ocusert system for sustained control OF ocular hypertension","volume":"93","author":"Macoul","year":"1975","journal-title":"Arch. Ophthalmol."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib138","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0975-7406.130965","article-title":"Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues","volume":"6","author":"Madaan","year":"2014","journal-title":"J. Pharm. BioAllied Sci."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib139","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jps.2600680411","article-title":"Pharmacokinetics OF topically applied pilocarpine IN th albino rabbit eye","volume":"68","author":"Makoid","year":"1979","journal-title":"J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2013.09.003","article-title":"Long-term trends in glaucoma-related blindness in olmsted county, Minnesota","volume":"121","author":"Malihi","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib141","first-page":"165","article-title":"Dendrimers: a tool for drug delivery","volume":"6","author":"Malik","year":"2012","journal-title":"Adv. Biol. Res."},{"issue":"13","key":"10.1016\/j.preteyeres.2020.100901_bib142","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1167\/iovs.12-10569","article-title":"Analysis of continuous 24-hour intraocular pressure patterns in glaucoma","volume":"53","author":"Mansouri","year":"2012","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.preteyeres.2020.100901_bib143","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1001\/archophthalmol.2012.2280","article-title":"Continuous 24-hour monitoring of intraocular pressure patterns with a contact lens sensor","volume":"130","author":"Mansouri","year":"2012","journal-title":"Arch. Ophthalmol."},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib144","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nmat3685","article-title":"Hybrid nanocolloids with programmed three-dimensional shape and material composition","volume":"12","author":"Mark","year":"2013","journal-title":"Nat. Mater."},{"issue":"7","key":"10.1016\/j.preteyeres.2020.100901_bib145","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1167\/iovs.06-1372","article-title":"Measurement of corneal swelling variations without removal of the contact lens during extended wear","volume":"48","author":"Martin","year":"2007","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.preteyeres.2020.100901_bib146","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bjo.42.6.321","article-title":"A recording tonometer","volume":"42","author":"Maurice","year":"1958","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib147","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/108076801753162807","article-title":"Review: practical issues in intravitreal drug delivery","volume":"17","author":"Maurice","year":"2001","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.preteyeres.2020.100901_bib148","first-page":"3","article-title":"Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy","volume":"11","author":"Mcmonnies","year":"2018","journal-title":"J. Optic."},{"key":"10.1016\/j.preteyeres.2020.100901_bib149","article-title":"Phase 3, randomized, 20-month study of bimatoprost implant in open-angle glaucoma and ocular hypertension (ARTEMIS 1) [published online ahead of print, 2020 Jun 13]","author":"Medeiros","year":"2020","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib150","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.xphs.2018.11.036","article-title":"Engineering and development of chitosan-based nanocoatings for ocular contact lenses","volume":"108","author":"Mehta","year":"2019","journal-title":"J. Pharmaceut. Sci."},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib151","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaophthalmol.2014.1739","article-title":"An implantable intraocular pressure transducer initial safety outcomes","volume":"132","author":"Melki","year":"2014","journal-title":"Jama Ophthalmology"},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib152","first-page":"211","article-title":"Overnight swelling OF the living human cornea","volume":"51","author":"Mertz","year":"1980","journal-title":"J. Am. Optom. Assoc."},{"issue":"12","key":"10.1016\/j.preteyeres.2020.100901_bib153","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s11095-012-0721-9","article-title":"Simulating intravitreal injections in anatomically accurate models for rabbit, monkey, and human eyes","volume":"29","author":"Missel","year":"2012","journal-title":"Pharmaceut. Res."},{"issue":"12","key":"10.1016\/j.preteyeres.2020.100901_bib154","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4155\/tde.14.75","article-title":"Advances in ophthalmic drug delivery","volume":"5","author":"Morrison","year":"2014","journal-title":"Ther. Deliv."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/exer.1996.0184","article-title":"A rat model of chronic pressure-induced optic nerve damage","volume":"64","author":"Morrison","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2020.100901_bib156","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/ma12020261","article-title":"Contact lens materials: a materials science perspective","volume":"12","author":"Musgrave","year":"2019","journal-title":"Materials"},{"key":"10.1016\/j.preteyeres.2020.100901_bib157","author":"Myers"},{"issue":"27","key":"10.1016\/j.preteyeres.2020.100901_bib158","first-page":"745","article-title":"Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced","volume":"6","author":"Nakada","year":"1998","journal-title":"US Patent"},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib159","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1371\/journal.pone.0024513","article-title":"Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye","volume":"6","author":"Natarajan","year":"2011","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.preteyeres.2020.100901_bib160","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1021\/jo00211a052","article-title":"Micelles .1. Cascade molecules - a new approach to micelles - a 27 -ARBOROL","volume":"50","author":"Newkome","year":"1985","journal-title":"J. Org. Chem."},{"issue":"7","key":"10.1016\/j.preteyeres.2020.100901_bib161","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","article-title":"The most common barriers to glaucoma medication adherence A cross-sectional survey","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib162","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s13346-015-0240-4","article-title":"A biodegradable ocular implant for long-term suppression of intraocular pressure","volume":"5","author":"Ng","year":"2015","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/j.preteyeres.2020.100901_bib163","series-title":"Gene Therapy","first-page":"259","article-title":"13 - dendrimers","author":"Nimesh","year":"2013"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib164","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","article-title":"Persistence and adherence with topical glaucoma therapy","volume":"140","author":"Nordstrom","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2020.100901_bib165","first-page":"1","article-title":"A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)","author":"Normando","year":"2020","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"7","key":"10.1016\/j.preteyeres.2020.100901_bib166","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1167\/iovs.19-27099","article-title":"Nicotinamide deficiency in primary open-angle glaucoma","volume":"60","author":"Nzoughet","year":"2019","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2020.100901_bib167","author":"Ocular Therapeutix"},{"key":"10.1016\/j.preteyeres.2020.100901_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1041-8","article-title":"Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin- related kinase receptor-B signaling","volume":"9","author":"Osborne","year":"2018","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.preteyeres.2020.100901_bib169","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1089\/hum.2017.069","article-title":"Design of a novel gene therapy construct to achieve sustained brain-derived neurotrophic factor signaling in neurons","volume":"29","author":"Osborne","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/jop.2012.0144","article-title":"Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure","volume":"29","author":"Ozkaya","year":"2013","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib171","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1167\/iovs.08-3013","article-title":"Effect of CNTF on retinal ganglion cell survival in experimental glaucoma","volume":"50","author":"Pease","year":"2009","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"21","key":"10.1016\/j.preteyeres.2020.100901_bib172","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/adhm.201600780","article-title":"Long-term subconjunctival delivery of brimonidine tartrate for glaucoma treatment using a microspheres\/carrier system","volume":"5","author":"Pek","year":"2016","journal-title":"Advanced Healthcare Materials"},{"issue":"14","key":"10.1016\/j.preteyeres.2020.100901_bib173","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.biomaterials.2010.01.113","article-title":"Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing Vitamin E diffusion barriers","volume":"31","author":"Peng","year":"2010","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib174","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/02713683.2011.630154","article-title":"Drug delivery by contact lens in spontaneously glaucomatous dogs","volume":"37","author":"Peng","year":"2012","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib175","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2012.06.017","article-title":"Extended drug delivery by contact lenses for glaucoma therapy","volume":"162","author":"Peng","year":"2012","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib176","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/00007611-197610000-00013","article-title":"Ocusert pilocarpine system - advantages and disadvantages","volume":"69","author":"Pollack","year":"1976","journal-title":"South. Med. J."},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib178","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/ICU.0b013e32834ff490","article-title":"Clinical trials for glaucoma neuroprotection are not impossible","volume":"23","author":"Quigley","year":"2012","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"11","key":"10.1016\/j.preteyeres.2020.100901_bib179","first-page":"3460","article-title":"Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats","volume":"41","author":"Quigley","year":"2000","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17425247.1.1.99","article-title":"Periocular routes for retinal drug delivery","volume":"1","author":"Raghava","year":"2004","journal-title":"Expet Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib181","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.joco.2017.09.002","article-title":"Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India","volume":"30","author":"Rajurkar","year":"2018","journal-title":"Journal of Current Ophthalmology"},{"issue":"Suppl. 2","key":"10.1016\/j.preteyeres.2020.100901_bib182","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1097\/ICL.0000000000000454","article-title":"Elemental composition at silicone hydrogel contact lens surfaces","volume":"44","author":"Rex","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.preteyeres.2020.100901_bib183","series-title":"Revista Brasileira de Oftalmologia","first-page":"432","article-title":"Adherence assessment of eye drops in patients with glaucoma using 8 item Morisky Score: a cross sectional study","volume":"vol. 75","author":"Ribeiro","year":"2016"},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib184","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1116\/1.590019","article-title":"Advanced techniques for glancing angle deposition","volume":"16","author":"Robbie","year":"1998","journal-title":"J. Vac. Sci. Technol. B"},{"key":"10.1016\/j.preteyeres.2020.100901_bib185","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.4103\/0301-4738.73693","article-title":"Compliance and adherence in glaucoma management","volume":"59","author":"Robin","year":"2011","journal-title":"Indian J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib186","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/jop.1992.8.317","article-title":"CONTINUOUS-FLOW contact-lens delivery OF gentamicin to rabbit cornea and aqueous-humor","volume":"8","author":"Rootman","year":"1992","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.preteyeres.2020.100901_bib187","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2016.03.064","article-title":"Retinal ganglion cell death in glaucoma: exploring the role of neuroinflammation","volume":"787","author":"Russo","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.preteyeres.2020.100901_bib188","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.optom.2018.12.003","article-title":"Advances in diagnostic applications for monitoring intraocular pressure in Glaucoma: a review","volume":"12","author":"Sanchez","year":"2019","journal-title":"Journal of Optometry"},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib189","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-0420.1996.tb00085.x","article-title":"A new drug delivery system utilizing piggyback contact lenses","volume":"74","author":"Sano","year":"1996","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.preteyeres.2020.100901_bib190","series-title":"Ophthalmic Drug Delivery Systems","first-page":"83","article-title":"Ocular pharmacokinectics\/pharmacodyamics","author":"Schoenwald","year":"1993"},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib191","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/jop.2018.0067","article-title":"Intracameral sustained-release bimatoprost implant delivers bimatoprost to target tissues with reduced drug exposure to off-target tissues","volume":"35","author":"Seal","year":"2019","journal-title":"J. Ocul. Pharmacol. Therapeut. : the official journal of the Association for Ocular Pharmacology and Therapeutics"},{"issue":"6","key":"10.1016\/j.preteyeres.2020.100901_bib192","first-page":"509","article-title":"Possibility of the application of ophthalmic drugs with the use of gel contact lenses","volume":"21","author":"Sedlacek","year":"1965","journal-title":"Cesk Oftalmol"},{"key":"10.1016\/j.preteyeres.2020.100901_bib193","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2147\/OPTH.S48766","article-title":"Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes","volume":"7","author":"Shafiee","year":"2013","journal-title":"Clin. Ophthalmol."},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib194","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1167\/iovs.13-13650","article-title":"Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown","volume":"55","author":"Shen","year":"2014","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2020.100901_bib241","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2147\/OPTH.S143428","article-title":"Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications","volume":"11","author":"Shen","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.preteyeres.2020.100901_bib195","article-title":"Targeted ocular drug delivery with pharmacokinetic\/pharmacodynamic considerations","volume":"35","author":"Shen","year":"2018","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib196","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.9.4.20","article-title":"Nonclinical pharmacokinetic and pharmacodynamic assessment of bimatoprost following a single intracameral injection of sustained-release implants","volume":"9","author":"Shen","year":"2020","journal-title":"Translational Vision Science & Technology"},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib197","first-page":"S320","article-title":"Multicenter, Phase 2 exploratory study evaluating the safety and efficacy of DEXTENZA for the treatment of dry eye disease","volume":"36","author":"Sheppard","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.preteyeres.2020.100901_bib198","doi-asserted-by":"crossref","first-page":"22","DOI":"10.15713\/ins.clever.24","article-title":"Sustained drug delivery platforms - a new era for gluacoma treatment","volume":"2","author":"Shouchane-Blum","year":"2019","journal-title":"Clinical and Experimental Vision and Eye Research"},{"key":"10.1016\/j.preteyeres.2020.100901_bib199","series-title":"Perspective: I. Paul Singh, MD, On the FDA Approval of Durysta","author":"Singh","year":"2020"},{"key":"10.1016\/j.preteyeres.2020.100901_bib200","article-title":"What\u2019s new with three sustained-release drug platforms","author":"Smolinsky","year":"2016","journal-title":"Ophthalmology Innovation Summit (OIS)"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib201","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00003226-199207000-00003","article-title":"Ocular surface residence times OF artificial tear solutions","volume":"11","author":"Snibson","year":"1992","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.preteyeres.2020.100901_bib202","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1021\/bm7008203","article-title":"Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells","volume":"8","author":"Stasko","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.preteyeres.2020.100901_bib203","series-title":"Highlights from the Optometric Management Symposium on Contemporary Eye Care","article-title":"Looking at Silicone Hydrogels across Generations:Demystify the various polymers and lens treatments that characterize silicone hydrogel lenses","author":"Szozotka-Flynn","year":"2008"},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib204","article-title":"Results of a phase 3, randomized, double-masked, vehicle controlled study (phase 3c) evaluating the safety and efficacy of DEXTENZA (TM) (dexamethasone insert) 0.4 mg for the treatment of ocular inflammation and pain after cataract surgery","volume":"58","author":"Talamo","year":"2017","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008682","article-title":"Rare protein-altering variants in ANGPTL7 lower intraocular pressure and protect against glaucoma","volume":"16","author":"Tanigawa","year":"2020","journal-title":"PLoS Genet."},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib206","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/stem.2095","article-title":"Molecular mechanisms mediating retinal reactive gliosis following bone marrow mesenchymal stem cell transplantation","volume":"33","author":"Tassoni","year":"2015","journal-title":"Stem Cell."},{"issue":"5","key":"10.1016\/j.preteyeres.2020.100901_bib207","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.preteyeres.2006.07.003","article-title":"Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences","volume":"25","author":"Tezel","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2020.100901_bib208","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06981-w","article-title":"Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery","volume":"9","author":"Than","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib209","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/ICL.0b013e318275452b","article-title":"A decade of silicone hydrogel development: surface properties, mechanical properties, and ocular compatibility","volume":"39","author":"Tighe","year":"2013","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.preteyeres.2020.100901_bib210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2019.05.059","article-title":"Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma","volume":"566","author":"Tighsazzadeh","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"13","key":"10.1016\/j.preteyeres.2020.100901_bib211","doi-asserted-by":"crossref","first-page":"9573","DOI":"10.1167\/iovs.11-7878","article-title":"Intraocular pressure measurement by radio wave telemetry","volume":"52","author":"Todani","year":"2011","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib212","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1295\/polymj.17.117","article-title":"A new class OF polymers - starburst-dendritic macromolecules","volume":"17","author":"Tomalia","year":"1985","journal-title":"Polym. J."},{"issue":"10","key":"10.1016\/j.preteyeres.2020.100901_bib213","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048188","article-title":"Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry","volume":"7","author":"Tyagi","year":"2012","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib214","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/mp300716t","article-title":"Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab","volume":"10","author":"Tyagi","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2020.100901_bib215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.exer.2013.10.023","article-title":"Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy","volume":"118","author":"Tzameret","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib216","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1167\/iovs.13-11825","article-title":"Mobility experiments with microrobots for minimally invasive intraocular surgery","volume":"54","author":"Ullrich","year":"2013","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib217","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1021\/nl404815q","article-title":"Conformal cytocompatible ferrite coatings facilitate the realization of a nanovoyager in human blood","volume":"14","author":"Venugopalan","year":"2014","journal-title":"Nano Lett."},{"issue":"8","key":"10.1016\/j.preteyeres.2020.100901_bib218","first-page":"1618","article-title":"Chronic low-dose glutamate is toxic to retinal ganglion cells - toxicity blocked by memantine","volume":"37","author":"Vorwerk","year":"1996","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2020.100901_bib219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.035","article-title":"Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment","volume":"214","author":"Voss","year":"2015","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.preteyeres.2020.100901_bib220","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500501","article-title":"Enzymatically active biomimetic micropropellers for the penetration of mucin gels","volume":"1","author":"Walker","year":"2015","journal-title":"Science Advances"},{"issue":"18","key":"10.1016\/j.preteyeres.2020.100901_bib221","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma A review","volume":"311","author":"Weinreb","year":"2014","journal-title":"Jama-Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib222","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1177\/112067219900901S09","article-title":"From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury","volume":"9","author":"Wheeler","year":"1999","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2020.100901_bib223","first-page":"62","article-title":"IVT injections: health policy implications","volume":"21","author":"Williams","year":"2014","journal-title":"Rev. Ophthalmol."},{"issue":"6326","key":"10.1016\/j.preteyeres.2020.100901_bib224","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B-3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2020.100901_bib225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/185117a0","article-title":"Hydrophilic gels for biological use","volume":"185","author":"Witcherle","year":"1960","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.preteyeres.2020.100901_bib226","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/ICU.0b013e3283459724","article-title":"Update on nonsurgical therapy for diabetic macular edema","volume":"22","author":"Witkin","year":"2011","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"12","key":"10.1016\/j.preteyeres.2020.100901_bib227","first-page":"2849","article-title":"Neuro-protection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension","volume":"42","author":"Woldemussie","year":"2001","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib228","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13346-014-0196-9","article-title":"Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops","volume":"4","author":"Wong","year":"2014","journal-title":"Drug Delivery and Translational Research"},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib229","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/jpet.102.047837","article-title":"Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024)","volume":"305","author":"Woodward","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"11","key":"10.1016\/j.preteyeres.2020.100901_bib230","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat4388","article-title":"A swarm of slippery micropropellers penetrates the vitreous body of the eye","volume":"4","author":"Wu","year":"2018","journal-title":"Science Advances"},{"issue":"2","key":"10.1016\/j.preteyeres.2020.100901_bib242","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clae.2007.09.002","article-title":"Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: A review","volume":"31","author":"Xinming","year":"2008","journal-title":"Contact Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.preteyeres.2020.100901_bib232","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2020.100901_bib233","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2018.05.020","article-title":"A comprehensive review on contact lens for ophthalmic drug delivery","volume":"281","author":"Xu","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2020.100901_bib234","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2019.05.025","article-title":"Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma","volume":"305","author":"Xu","year":"2019","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.preteyeres.2020.100901_bib235","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1021\/nn301873v","article-title":"Hybrid dendrimer hydrogel\/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration","volume":"6","author":"Yang","year":"2012","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib236","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s10792-017-0601-8","article-title":"The efficacy and safety of bimatoprost\/timolol maleate, latanoprost\/timolol maleate, and travoprost\/timolol maleate fixed combinations on 24-h IOP","volume":"38","author":"Yilmaz","year":"2018","journal-title":"Int. Ophthalmol."},{"issue":"4","key":"10.1016\/j.preteyeres.2020.100901_bib237","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbrc.2006.03.231","article-title":"Effects of bone marrow stromal cell injection in an experimental glaucoma model","volume":"344","author":"Yu","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.preteyeres.2020.100901_bib238","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.2042-7158.1986.tb04611.x","article-title":"A comparison OF the effect OF viscosity ON the precorneal residence OF solutions IN rabbit and man","volume":"38","author":"Zaki","year":"1986","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.preteyeres.2020.100901_bib239","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2017.09.029","article-title":"Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site","volume":"266","author":"Zhao","year":"2017","journal-title":"J. Contr. Release"}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946220300732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946220300732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:39:34Z","timestamp":1761172774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946220300732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":240,"alternative-id":["S1350946220300732"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100901","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100901"}}